Targeting breast cancer stem cells directly to treat refractory breast cancer
Frontiers in Oncology · 12.05.2023 · 13
DOI: 10.3389/fonc.2023.981247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 12.05.2023. Verfasst von Liping Pan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wuhan Center for Clinical Laboratory, Wuhan, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
For patients with refractory breast cancer (BC), integrative immunotherapies are emerging as a critical component of treatment. However, many patients remain unresponsive to treatment or relapse after a period. Different cells and mediators in the tumor microenvironment (TME) play important roles in the progression of BC, and cancer stem cells (CSCs) are deemed the main cause of relapse. Their characteristics depend on their interactions with their microenvironment as well as on the inducing factors and elements in this environment. Strategies to modulate the immune system in the TME of BC that are aimed at reversing the suppressive networks within it and eradicating residual CSCs are, thus, essential for improving the current therapeutic efficacy of BC. This review focuses on the development of immunoresistance in BCs and discusses the strategies that can modulate the immune system and target breast CSCs directly to treat BC including immunotherapy with immune checkpoint blockades.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wuhan Center for Clinical Laboratory, Wuhan, China.
- Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zitieren
APA
Pan, L., Han, J., & Lin, M. (2023). Targeting breast cancer stem cells directly to treat refractory breast cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.981247
Vancouver
Pan L, Han J, Lin M. Targeting breast cancer stem cells directly to treat refractory breast cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.981247
BibTeX
@article{Pan2023,
author = {Pan, Liping and Han, Juan and Lin, Ming},
title = {Targeting breast cancer stem cells directly to treat refractory breast cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.981247}
}
EUVIMED